Tainted batches of heparin may have raised concerns with the general public, but a recent Reuters report suggests the U.S. Food and Drug Administration (FDA) would rather focus on giving product promotion advice to companies and journal reprints to physicians than food and drug safety scares. The FDA also planned to change its regulations to protect device makers’ FDA-approved products from lawsuits with a so-called preemptive clause, according to Reuters. The news agency says that in a letter from California Rep. Henry Waxman, to FDA Commissioner Andrew von Eschenbach, Waxman raised concerns that the items outlined on the FDA’s 2007 priorities ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.